Abiopharma

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Xylo Technologies Ltd. - American Depositary Shares.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Xylo Technologies Ltd. - American Depositary Shares.

NASDAQ traded attribute type Security_Name was changed. Previous value: Xylo Technologies Ltd. - American Depositary Shares. New value: Xylo Technologies Ltd. - American Depositary Shares.

HUTCHMED Announces Appointment of Acting Chief Executive Officer

LNTH Investors Have Opportunity to Join Lantheus Holdings, Inc. Fraud Investigation with the Schall Law Firm

SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm

The Best Mini PCs for Gaming

Best Bose Soundbar Models (2025)

Best Curved Gaming Monitors in 2025

Best Digital Cameras for Photography Enthusiasts in 2025

Best Gaming Keyboards for Professional Gamers in 2025

Piramal Pharma Solutions und NewAmsterdam Pharma investieren in einen spezialisierten Produktionsbereich, um die Herstellungskapazitäten fester oraler Darreichungsformen am Piramal-Standort in Sellersville, Pennsylvania, zu erweitern USA - Deutsch USA - English USA - English España - español USA - Français Italia - Italiano

Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting

Xbox Series X Storage Guide and New Expansion Options (2025)

Everything Coming to HBO Max in September 2025